Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Clinical trial NCT02304367 · COMPLETED

Trial details

NCT number: NCT02304367
Sponsor: Kyowa Kirin, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tumor Induced Osteomalacia (TIO)Epidermal Nevus Syndrome (ENS)

Start date: 2015-03-24
Primary completion: 2017-07-27
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.